Publication | Open Access

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice

InflammationMetabolic SyndromeVascular DiseaseMedicineDiabetesPhysiologyPharmacologyDiabetic Kidney DiseaseEndothelial DysfunctionVascular BiologyMicrovascular DysfunctionChronic Kidney DiseaseAtherosclerosisNephrologyHealth Sciences